ArticleFrontiers in oncology2024

Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis.

Céline Eldani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.